Early Complications and Results of Preserflo MicroShunt in the Management of Uncontrolled Open-Angle Glaucoma: A Case Series

We analyze the surgical outcomes and early complications with their management of the Preserflo MicroShunt (Santen Pharmaceutical Co., Ltd., Osaka, Japan) at six-month follow-up. The study is conducted between March 2021 and May 2022. Best-corrected visual acuity (BCVA) logMAR, intraocular pressure...

Descripción completa

Detalles Bibliográficos
Autores principales: Saeed, Emil, Zalewska, Renata, Konopińska, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315655/
https://www.ncbi.nlm.nih.gov/pubmed/35886531
http://dx.doi.org/10.3390/ijerph19148679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315655/
https://www.ncbi.nlm.nih.gov/pubmed/35886531
http://dx.doi.org/10.3390/ijerph19148679

Ejemplares similares